DOI: https://doi.org/10.21203/rs.3.rs-103439/v1
The pandemic of coronavirus disease 2019 (Covid-19) caused a large number of non-ventilated hypoxemic patients to require the use of prone position.
The aim of this study is to measure the efficiency and tolerance of prone positioning in ward hypoxemic patients treated for Covid-19.
This retrospective study included confirmed Covid-19 hypoxemic patients treated by at least one prone position session. Primary outcome was pulse oximetry over inspired oxygen fraction ratio (SpO2/FiO2) before, during and after prone position. Secondary outcomes were failure, adverse events and poor tolerance rate.
Twenty-seven patients were included. During first, second and third sessions, SpO2/FiO2 ratio was significantly higher during posture than before (p<0.0001, p<0.01 and p<0.01 respectively). Eighteen patients were responders (defined as an improvement of SpO2/FiO2 of more than 50) during the first posture and have a shorter length of hospital stay than non-responders patients. Failure rate was 5 %, poor tolerance and adverse events rates were 8 % and 7 % respectively.
Our study found that prone position in wards improved alveolar exchange during posture and is well-tolerated. This technique could be used in any medical ward.
The coronavirus disease 2019 (Covid-19) pandemia expansion was responsible for an overload of patients who developed an acute respiratory failure [1]. Many critical hypoxemic patients were treated in wards due to lack of intensive care units (ICU) bed availability. Despite the data scarcity in conscious non-mechanically ventilated patients, prone positioning was broadly suggested in this context. The aim of our study was to evaluate the efficiency and tolerance of prone positioning in non-ICU patients.
We conducted a retrospective study in Paris Saint-joseph hospital wards between March 15 and July 6 2020. Confirmed Covid-19 hypoxemic patients who benefited from at least one prone position were included. Patients were not included if they had less than 4L/min oxygen flow. This study was approved by the Paris Saint-Joseph hospital institutional review board and registered following the French Reference Methodology MR-004. Anonymous data were collected in the absence of opposition of the patients to the use of their data.
The main outcome was the SpO2/FiO2 evolution, estimated by pulse oximetry (SpO2) and inspired oxygen fraction (FiO2) collected immediately before, during and after each set up. We also compared patients who responded and those who did not: responders were defined as an improvement of SpO2/FiO2 of more than 50. Secondary outcomes were (i) immediate failure to sustain posture (ii) adverse events (desaturation, modification in blood pressure or heart rate, vomiting) during prone position (iii) poor-tolerance (impossibility to withstand the position due to subjectives reasons such as: onset or increase of pain, worsening of dyspnea, uncomfort or anxiety).
Main outcome analysis was made using Friedman paired tests and Dunn’s post-test. Continuous variables were presented as median with interquartile range (IQR) due to their distribution. Categorical variables were expressed as numbers with percentages. Statistics were processed using the R software with a two-sided 5% significance threshold. When necessary, 95% confidence intervals (95% CI) are presented. Figures were created using GraphPad Prism 8 software.
We included 27 patients out of 38 eligible patients: 11 patients were not included because flow oxygen was under 4L/min at the first prone position.
The median age of patients was 73 years (IQR, 60-79). Fifty-nine percent were male (n = 16) and the median body mass index (BMI) was 28.1 (IQR, 25.4-32.8). The most common comorbidities were arterial hypertension (n = 13, 48%), chronic obstructive pulmonary disease (n = 7, 26%) and type II diabete (n = 6, 22%). One patient (4%) was an active smoker while 13 patients were former smokers (48 %). The remaining patients had never smoked (n = 13, 48%).
Lesion severity on computerized tomography scan was moderate (10-25%) for 7 patients (26%), extensive (25-50%) for 10 patients (37%), severe (50-75%) for 8 patients (30%) and critical (over 75%) for one patient (4%). The first prone position was achieved at a median duration of 2 days after hospital admission. Seventy-four percent of patients (n = 20) were on oxygen flow rates of at least 6 L/min and SpO2/FiO2 median ratio was 187.5 (IQR, 161.6-211.2). Median duration of hospital length of stay was 16 days (IQR, 9-24). One patient died during hospitalisation.
Twenty-four patients completed the first prone position: the median SpO2/FiO2 ratio was 342.5 (238.9-438.1) which was significantly higher than the 188.5 (162.5-216.9) before prone position (p<0.0001). There was no difference in SpO2/FiO2 before and after posturing: 188.5 (162.5-216.9) vs 200.0 (173.4-234.4). Similar results were found during the next posture sessions. Results are presented in figure 1.
During the first posture, 18 patients were responders. Moreover, responding and non-responding patients did not differ from one another, except for length of hospital stay, which is shorter for responding patients (table1).
Considering the 64 episodes of postures no serious adverse event has occurred. Three postures were impossible to sustain immediately, 2 for anxiety and 1 for desaturation: the failure rate of prone position was estimated to be 5% (95% CI, 1%-13%). Among the 61 sessions, 7 desaturations have occurred: the adverse event rate was estimated to be 7% (95% CI, 2%-16%). Finally, the prone position poor-tolerance frequency was estimated to be 8% (95% CI, 3%-18%): 2 for onset of pain and 3 for severe uncomfort.
Our results confirm that prone position improved Covid-19 patients’ alveolar oxygen exchange in ward patients and is well-tolerated.
Several studies have been recently published about prone position in covid-19 patients. Elharrar et al. have yet ascertained that only 25 % were responders to prone position [2]. However, our study showed more promising results: other studies have found the same trends as ours in oxygenation improvement during the posture [3–5]. Sartini et al. found that 12 of 15 patients had persistent oxygenation improvement after the posture’s end [3]. In our study, oxygenation improvement didn't seem to persist when the position was stopped: therefore our results seem consistent with findings from previous studies [2,4]. There is some heterogeneity in literature regarding oxygenation improvement during and after posture: this could be due to a substantial difference in time measurement itself or because outcomes, populations (e.g: age and body mass index) and associated treatments (e.g: non-invasive ventilation during posture) were different.
The results of our secondary outcomes were consistent with previous findings and suggested that difficulties encountered are rather scarce and mild [2–4,6].
There are several limitations in this study. Firstly, it was a retrospective study from a single center. Moreover, homogeneity of patients and unicity of the pathology made the results transposable in other locations. Secondarily, the SpO2/FiO2 ratio probably lacks precision but is correlated with PaO2/FiO2 ratios [7] and is quite less invasive for conscious patients. Finally, the absence of randomization reduced our level of evidence, nonetheless, the variations of SpO2/FiO2 during and after prone position tend to confirm the efficiency and the transient nature of the effect.
In conclusion, prone position is easy to implement in wards, improves alveolar exchange during posture and is well tolerated. Results need confirmation in randomized and high quality studies. Moreover, the benefit of this technique on intubation or mortality is currently unknown.
Acknowledgements:
We would like to thank Marie Lavigne, Layla Ninot, Aurel Bellaïche and all the physiotherapists, nurses, and health-care staff involved in the implementation of prone position with Covid-19 patients.
Funding
The authors did not receive support from any organization for the submitted work.
Conflicts of interest/Competing interests
The authors declare that they have no conflict of interest.
Ethics approval
This study was approved by the Paris Saint-Joseph hospital institutional review board (IRB 00012157) and registered following the French Reference Methodology MR-004.
Consent to participate
Anonymous data were collected in the absence of opposition of the patients to the use of their data.
Availability of data and material
The datasets used and/or analysed during the current study are available from the corresponding author on reasonable request.
Code availability
Not applicable.
Author contributions:
JW, CR and FP conceived and planned the following research. JW performed the data collection, the statistics analysis and designed the figure with support from FP. JW and CR wrote the manuscript with support from FP. All authors provided critical feedback of the research and manuscript.
Table 1 Characteristics of responders and non-responders patients
Characteristics |
First PP responders (n=18) |
First PP non responders (n=6) |
p- value |
|
Age, median (IQR) |
71 (61.2-80.0) |
64.5 (46.5-76.5) |
0.404 |
|
Sex, No. (%) |
|
|
|
|
|
Female |
7 (39) |
4 (67) |
0.357 |
|
Male |
11 (61) |
2 (33) |
|
BMI, median (IQR)a |
28.1 (25.4-32.0) |
25.6 (24.1-25.9) |
0.173 |
|
Smoking history, No. (%) |
|
|
|
|
|
Active smoker |
1 (6) |
0 (0) |
0.745 |
|
Former smoker |
8 (44) |
2 (33) |
|
|
Never smoked |
9 (50) |
4 (67) |
|
Comorbidities, No. (%) |
|
|
|
|
|
Chronic Obstructive Pulmonary Disease |
4 (22) |
1 (17) |
1 |
|
Hypertension |
9 (50) |
1 (17) |
0.341 |
|
Type II diabetes |
2 (11) |
2 (33) |
0.251 |
Severity of CT damage, No. (%)a |
|
|
|
|
|
Moderate (10-25 %) |
4 (24) |
2 (33) |
0.426 |
|
Extensive (25-50 %) |
7 (41) |
2 (33) |
|
|
Severe (50-75 %) |
6 (35) |
1 (17) |
|
|
Critical (> 75 %) |
0 (0) |
1 (17) |
|
Medical treatment at inclusion, No. (%) |
|
|
|
|
|
Hydroxychloroquine |
9 (50) |
4 (67) |
0.649 |
|
Azithromycin |
13 (72) |
4 (67) |
1 |
|
Anakinra |
13 (72) |
3 (50) |
0.362 |
|
Antibiotics |
17 (94) |
4 (67) |
0.143 |
SpO2/FiO2 ratio before first PP, median (IQR) |
190.6 (185.9-216.9) |
172.0 (156.7-188.0) |
0.182 |
|
Oxygen flow before first PP, median (IQR) |
6 (4.5-6) |
7.5 (6.0-9.0) |
0.321 |
|
|
< 6 L/min, No. (%) |
5 (28) |
1 (17) |
1 |
|
≥ 6 L/min, No. (%) |
13 (72) |
5 (83) |
|
Length of stay in hospital, median (IQR) |
10.50 (8.25-18.25) |
26 (19.00-35.25) |
0.013 |
A responder to the posture was considered as such by an improvement of the measured SpO2/FiO2 ratio by at least 50 points. a Missing data: BMI for 3 patients and 1 for CT-scan severity. Abbreviations: IQR: interquartile range, BMI: body mass index, PP: prone position, CT: computerized tomography, SpO2: pulse oximetry, FiO2: inspired oxygen fraction